Upstream Bio, Inc. (UPB)
5.34
+0.03
(+0.56%)
USD |
NASDAQ |
Sep 18, 16:00
5.35
+0.01
(+0.19%)
Pre-Market: 20:00
Upstream Bio Cash from Operations (Quarterly) : -35.62M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -35.62M |
| March 31, 2026 | -47.85M |
| December 31, 2025 | -30.63M |
| September 30, 2025 | -22.24M |
| Date | Value |
|---|---|
| June 30, 2025 | -39.24M |
| March 31, 2025 | -41.16M |
| December 31, 2024 | -19.61M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Sutro Biopharma, Inc. | -38.29M |
| Compass Therapeutics, Inc. | -14.74M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Anika Therapeutics, Inc. | -0.684M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 15.76M |
| Cash from Financing (Quarterly) | 2.533M |
| Free Cash Flow | -136.46M |
| Free Cash Flow Per Share (Quarterly) | -0.6528 |
| Free Cash Flow to Equity (Quarterly) | -35.46M |
| Free Cash Flow to Firm (Quarterly) | -35.62M |
| Free Cash Flow Yield | -47.09% |